News

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.
Both new doses can be bought for $499 for a month's supply via the company's LillyDirect direct-to-consumer self-pay channel, $150 lower than it charges for the injector pen formulations of those ...
As summer approaches, millions of Americans are turning to weight-loss injections in hopes of shedding pounds—fast. Roughly ...
Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...
International study looked at 800 patients in 37 countries Patients getting the drug saw less inflammation and fat in their livers Lead researcher says it could help treat liver disease like MASH ...
It’s not specific to Ozempic. It can happen with any of the oh, so popular medications like Wegovy, Zepbound and ... This can include the injection of filler into locations that have lost ...
Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.
While these injectable medications have gained in popularity for their dramatic effects, few people realise that your body ...
A. There is growing evidence that medications like semaglutide (Wegovy, Ozempic) can reduce drinking, even for people with alcohol problems (Journal of Clinical Investigation, March 6, 2025).
Wegovy and semaglutide-based diabetes therapy Ozempic – which grew 12% to DKK 33.85 billion in the fourth quarter – have been the driving force behind Novo Nordisk's sector-beating growth ...
The company’s portfolio features a large range of products including cartridges for auto-injector pens, prefillable syringes for a wide variety of biologics, vials, ampoules, as well as ...
The FDA has approved ten GLP-1 medications for diabetes management, like Wegovy and Ozempic. Six are approved for weight management. The demand recently exceeded FDA approved manufacturers' ability to ...